NASDAQ · Medical - Devices

Bone Biologics Corp (BBLG) Stock

$0.47 -0.43% NASDAQ: BBLG Healthcare

Valuation

MetricValue
Price$0.47
Market Cap$845628
P/E Ratio-0.26
P/B Ratio0.22
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$2.89
52-Week Low$0.46
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-57.85%
ROA-65.16%
ROCE-78.01%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-4.0M$-9.0M$-4.0M$-3.0M
Net Profit$-2.0M$-1.0M$-9.0M$-4.0M$-3.0M
EPS$-37.35$-31.20$-34.01$-4.83$-2.65
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$7.0M$8.0M$4.0M$4.0M$6.0M
Total Liabilities$0$3.0M$1.0M$0$0
Cash$7.0M$8.0M$3.0M$3.0M$5.0M
Borrowings$0$0$0$0$0

Latest News

BBLG Secures Financing for Critical Trials Zacks Small Cap Research · Jul 8, 2026 Bone Biologics Prices Up to $9 Million Private Placement of Stock, Warrants MT Newswires · Jul 8, 2026 Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules GlobeNewswire · Jul 8, 2026 Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1 GlobeNewswire · May 19, 2026 BBLG In Good Shape as Critical Tests Underway Zacks Small Cap Research · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-4.0M$-10.0M$-4.0M$-3.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$5.0M$0
Net Cash Flow$7.0M$1.0M$-5.0M$0$2.0M
Free Cash Flow$-1.0M$-4.0M$-10.0M$-4.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA1.45
FCF Yield-299.28%
Quick Ratio8.67
Interest Coverage0.00
Return 1Y-57.24%
Return 3Y-98.11%
Return 5Y—

Ownership

Insiders Held0.04%
Institutions Held0.25%
Institutions Float Held0.25%
Institutional HolderSharesReport Date
Tower Research Capital LLC (TRC)4,1262026-03-31
SBI Securities Co., Ltd.2302026-03-31
UBS Group AG562026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Bone Biologics Corp

Bone Biologics Corp is led by CEO Jeffrey Frelick, employs 2 people, headquartered in US, publicly traded since 2021.

Bone Biologics Corp (BBLG) stock trades at $0.47 with a market capitalization of $845628. The stock is valued at a price-to-earnings (P/E) ratio of -0.26, price-to-book of 0.22, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.46 and $2.89, and currently trades 83.7% below its 52-week high.

On profitability, Bone Biologics Corp generates a return on equity (ROE) of -57.85%, return on capital employed of -78.01%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides